Does BEVACIZUMAB Cause Metastatic neoplasm? 133 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 133 reports of Metastatic neoplasm have been filed in association with BEVACIZUMAB (JOBEVNE). This represents 0.2% of all adverse event reports for BEVACIZUMAB.
133
Reports of Metastatic neoplasm with BEVACIZUMAB
0.2%
of all BEVACIZUMAB reports
65
Deaths
35
Hospitalizations
How Dangerous Is Metastatic neoplasm From BEVACIZUMAB?
Of the 133 reports, 65 (48.9%) resulted in death, 35 (26.3%) required hospitalization, and 3 (2.3%) were considered life-threatening.
Is Metastatic neoplasm Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BEVACIZUMAB. However, 133 reports have been filed with the FAERS database.
What Other Side Effects Does BEVACIZUMAB Cause?
Off label use (12,094)
Death (8,493)
Diarrhoea (4,911)
Disease progression (4,653)
Fatigue (4,572)
Nausea (4,357)
Hypertension (4,309)
Anaemia (3,221)
Vomiting (3,193)
Neutropenia (2,875)
What Other Drugs Cause Metastatic neoplasm?
TRASTUZUMAB (120)
CAPECITABINE (102)
PACLITAXEL (102)
CARBOPLATIN (89)
LEUPROLIDE (84)
DOCETAXEL (72)
ADALIMUMAB (71)
RANITIDINE (71)
DENOSUMAB (68)
CLOZAPINE (65)
Which BEVACIZUMAB Alternatives Have Lower Metastatic neoplasm Risk?
BEVACIZUMAB vs BEVACIZUMAB-AWWB
BEVACIZUMAB vs BEVACIZUMAB-BVZR
BEVACIZUMAB vs BEVACIZUMAB-MALY
BEVACIZUMAB vs BEXAROTENE
BEVACIZUMAB vs BEYAZ